Apple, Samsung Must Stop Some Korea Sales In Patent Fight
Apple Inc. (AAPL), the maker of the iPhone, and Samsung Electronics Co. (005930) infringed each other's patents for mobile devices and must stop selling some products in South Korea and pay damages, a Seoul court said.
Context & Ripple Effects
This ruling closes the loop on a fight that opened with Apple's April 2011 patent suit against Samsung's Galaxy line, which turned the iPhone maker's component supplier into its chief courtroom adversary. The Seoul decision is unusual because it cuts both ways: as the court's finding puts it, each company infringed the other's patents, so both face partial sales bans and damages in South Korea.
The story traveled widely — picked up by Reuters, the Associated Press, CNET, and others within a day — reflecting how much of the global smartphone market now hinges on these two companies' litigation posture. It lands just ahead of Samsung's well-received Galaxy S III flagship cycle and amid reports that Chinese buyers are already delaying iPhone purchases or switching brands, where an IHS tally puts Apple at only No. 7 in that market.
First-order effects
- Both Apple and Samsung must pull some products from Korean store shelves and pay court-ordered damages — a direct hit to Samsung on its home turf and to Apple in one of its few markets where it competes head-to-head with Samsung's domestic brand advantage.
Second-order effects
- Samsung must weigh whether the Galaxy S III's sales momentum survives even a narrow ban, while Apple faces pressure in growth markets like China where purchase delays and brand-switching are already eroding share ahead of any next-model launch.
Third-order effects
- If mutual-infringement findings keep landing across jurisdictions, the economics of exclusionary bans give way to pressure for cross-licensing deals, reshaping how smartphone patents function — less as weapons that remove rivals' products, more as royalty claims settled between the two dominant players.
The trend: Smartphone patent disputes are escalating into simultaneous multi-country battles where courts increasingly rule against both sides, pushing the industry toward negotiated cross-licensing rather than outright product bans.